Replies to post #215259 on Biotech Values

[bladerunner1717]

re: ADXS

Dew,

(Thanks for all your work on RVNC.)

Do you expect ADXS to do a raise before year-end? How would you assess ADXS' financial position as of today and going forward?


Bladerunner

[DewDiligence]

(ADXS)—PETX wins conditional approval for treating canine osteosarcoma:

https://finance.yahoo.com/news/aratana-therapeutics-granted-conditional-license-130500431.html

The product, AT-014, uses the listeria-based antigen delivery system developed by ADXS. (ADXS is +10% today on this news.)